The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. The company has a significant Indefinite Delivery Contract (IDC) valued at up to $600 million with the Department of Veterans Affairs (VA) for providing surgical implants and related products and services through December 2028, highlighting Medtronic's critical role as a prime supplier of advanced medical technologies to the federal government.
Generated 3/7/25, 9:52 AM